Clinical Trial Update: Placement of CS/LV Pacing Leads With EnSite NavX Guidance [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating placement of CS/LV pacing leads with EnSite NavX guidance has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | EARLY_Phase 1 | Status: WITHDRAWN